EP3549599
Mótefni gegn CSF-1R
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
26.8.2014EP published:
6.9.2023EP application number:
19171833.7
EP translation filed:
6.11.2023Grant published:
15.12.2023EPO information:
European Patent Register
Max expiry date:
25.8.2034Expiry date:
25.8.2026Next due date:
31.8.2026
Title in English:
ANTIBODIES AGAINST CSF-1RLanguage of the patent:
English
Timeline
Today
26.8.2014EP application
6.9.2023EP Publication
6.11.2023Translation submitted
15.12.2023Registration published
25.8.2026Expires
Owner
Name:
UCB Biopharma SRLAddress:
Allée de la Recherche 60, 1070 Brussels, BE
Inventor
Name:
CRAGGS, GrahamAddress:
Slough, Berkshire SL1 3WE, GB
Name:
HERVÉ, Karine Jeannine MadeleineAddress:
Slough, Berkshire SL1 3WE, GB
Name:
MARSHALL, DianeAddress:
Slough, Berkshire SL1 3WE, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201315487Date:
30.8.2013Country:
GB
Classification
Categories:
A61K 39/00, A61P 11/00, A61P 35/00, C07K 16/28
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 9.7.2024
Expires: 25.8.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 9.7.2024
Expires: 25.8.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 11.8.2025
Expires: 25.8.2026
Payer: Árnason Faktor ehf.